Patents by Inventor Jeongwoo Kang

Jeongwoo Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISPLAY APPARATUS AND CONTROL METHOD THEREFOR
    Publication number: 20230262191
    Abstract: A method performed by a display apparatus, includes: outputting, by a video processor, a video frame comprising a first area corresponding to area information for the video frame; outputting a graphic frame; generating transparency information corresponding to the area information of the video frame; providing the area information of the video frame and the generated transparency information; adjusting a transparency of a second area of the graphic frame based on the area information and the transparency information; and outputting an image overlapping the video frame and the graphic frame comprising the second area having the adjusted transparency.
    Type: Application
    Filed: April 3, 2023
    Publication date: August 17, 2023
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Jaeseong KIM, Jeongwoo Kang, Daesung Lim, Myoungkoo Choi, Yunho Choi
  • Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
    Patent number: 7387895
    Abstract: The present invention relates to a hybridoma cell line producing a PPAR gamma-specific monoclonal antibody, and a method for detecting a PPAR gamma ligand related to the progression of difficult diseases, such as cancer, inflammation and metabolic diseases obesity and diabetes), using the PPAR gamma-specific monoclonal antibody. This PPAR gamma-specific monoclonal antibody and the method for screening a PPAR gamma ligand using the monoclonal antibody will be commercially used for screening a PPAR gamma regulator related to diseases such as inflammatory, cancer and metabolic diseases, and also will serve as an useful tool for analyzing the function of such a ligand.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: June 17, 2008
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Doyoung Yoon, Haesook Lee, Minchul Cho, Kyungae Lee, Kyungjoo Cho, Jeongwoo Kang, Junghyun Shim, Jongseok Lim, Jintae Hong, Heegu Lee, Yongkyung Choe
  • Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
    Publication number: 20060140938
    Abstract: The present invention relates to a hybridoma cell line producing a PPAR gamma-specific monoclonal antibody, and a method for detecting a PPAR gamma ligand related to the progression of difficult diseases, such as cancer, inflammation and metabolic diseases obesity and diabetes), using the PPAR gamma-specific monoclonal antibody. This PPAR gamma-specific monoclonal antibody and the method for screening a PPAR gamma ligand using the monoclonal antibody will be commercially used for screening a PPAR gamma regulator related to diseases such as inflammatory, cancer and metabolic diseases, and also will serve as an useful tool for analyzing the function of such a ligand.
    Type: Application
    Filed: October 16, 2003
    Publication date: June 29, 2006
    Inventors: Doyoung Yoon, Haesook Lee, Minchul Cho, Kyungae Lee, Kyungjoo Cho, Jeongwoo Kang, Junghyun Shim, Jongseok Lim, Jintae Hong, Heegu Lee, Youngkyung Choe